Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Gene therapy finds its niche

An Erratum to this article was published on 06 May 2011

This article has been updated

Gene therapy is finally poised to make a contribution to the treatment of debilitating, highly penetrant genetic diseases that have proved intractable to other regimens.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Different types of gene therapy vector.
Figure 2: Breakdown of vectors used in gene therapy trials.

Change history

  • 12 April 2011

    In the version of the article originally published, Table 1 left off AAV as a section heading. A number of products listed under Adenovirus should have been listed under AAV. Neurologix product NLXP10 was incorrectly listed under the heading of retrovirus, and in phase 2 of development. It should be listed under the heading AAV, and the phase of development should have read phase 2 completed. The errors have been corrected in the HMTL and PDF versions of the article.

References

  1. Friedmann, T. Nat. Genet. 2, 93–98 (1992).

    Article  CAS  Google Scholar 

  2. Friedmann, T. & Roblin, R. Science 175, 949–955 (1972).

    Article  CAS  Google Scholar 

  3. Anonymous. Nat. Med. 6, 1 (2000).

  4. Hacein-Bey-Abina, S. et al. J. Clin. Invest. 118, 3132–3142 (2008).

    Article  CAS  Google Scholar 

  5. Fischer, A. et al. Nat. Immunol. 11, 457–460 (2010).

    Article  CAS  Google Scholar 

  6. http://storm.zoomvisionmamato.com/player/diamyd_medical/objects/7c8rv49g/ (Accessed 26 October 2010).

  7. Mitomo, K. et al. Mol. Ther. 18, 1173–1182 (2010).

    Article  CAS  Google Scholar 

  8. Aiuti, A. et al. N. Engl. J. Med. 360, 447–458 (2009).

    Article  CAS  Google Scholar 

  9. Naldini, L. et al. Science 272, 263–267 (1996).

    Article  CAS  Google Scholar 

  10. Bartus, R.T. et al. Mov. Disord. published online, doi: 10.1002/mds.23442 (18 November 2010).

  11. Lock, M. et al. Hum. Gene Ther. 21, 1273–1285 (2010).

    Article  CAS  Google Scholar 

  12. Friedmann, T. Nat. Genet. 2, 93–98 (1992).

    Article  CAS  Google Scholar 

  13. Wade, N. Science 212, 24–25 (1981).

    Article  CAS  Google Scholar 

  14. Blaese, R.M. et al. Science 270, 475–480 (1995).

    Article  CAS  Google Scholar 

  15. Bordignon, C. et al. Science 270, 470–475 (1995).

    Article  CAS  Google Scholar 

  16. Branca, M.A. Nat. Biotechnol. 23, 519–521 (2005).

    Article  CAS  Google Scholar 

  17. Cavazzana-Calvo, M. et al. Science 288, 669–672 (2000).

    Article  CAS  Google Scholar 

  18. Guo, J. & Xin, H. Science 314, 1232–1235 (2006).

    Article  CAS  Google Scholar 

  19. Levine, B.L. et al. Proc. Natl. Acad. Sci. USA 103, 17372–17377 (2006).

    Article  CAS  Google Scholar 

  20. Maguire, A.M. et al. Lancet 374, 1597–1605 (2009).

    Article  CAS  Google Scholar 

  21. Cavazzana-Calvo, M. et al. Nature 467, 318–322 (2010).

    Article  CAS  Google Scholar 

  22. Hyde, S.C. et al. Nat. Biotechnol. 26, 549–551 (2008).

    Article  CAS  Google Scholar 

  23. Akinc, A. et al. Nat. Biotechnol. 26, 561–569 (2008).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sheridan, C. Gene therapy finds its niche. Nat Biotechnol 29, 121–128 (2011). https://doi.org/10.1038/nbt.1769

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.1769

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research